SCHEMBL3408546

SCHEMBL3408546

O=C(O)N(c1ccncc1[N+](=O)[O-])C1CCCNC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RPLP1 P05386 10/20 0.39
RPLP0 P05388 10/20 0.39
RPS17 P08708 10/20 0.39
RPSA P08865 10/20 0.39
RPS2 P15880 10/20 0.39
RPL35A P18077 10/20 0.39
RPL7 P18124 10/20 0.39
RPL17 P18621 10/20 0.39
RPS4Y1 P22090 10/20 0.39
RPS3 P23396 10/20 0.39
RPS12 P25398 10/20 0.39
RPL13 P26373 10/20 0.39
RPL10 P27635 10/20 0.39
RPL12 P30050 10/20 0.39
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 10/20 0.39
RPL22 P35268 10/20 0.39
RPL4 P36578 10/20 0.39
RPS19 P39019 10/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445165 0.87 RPLP1 (0.35) MEN1KMT2ARPLP1RPLP0RPS17
SCHEMBL3412297 0.86 RPLP1 (0.35) MEN1KMT2ARPLP1RPLP0RPS17
SCHEMBL3412292 0.86 RPLP1 (0.35) MEN1KMT2ARPLP1RPLP0RPS17
SCHEMBL4443619 0.86 RPLP1 (0.35) MEN1KMT2ARPLP1RPLP0RPS17
SCHEMBL4438003 0.83 PCSK9 (0.36) MEN1KMT2ARPLP1RPLP0RPS17
SCHEMBL4436107 0.81 MEN1 (0.35) MEN1KMT2A
SCHEMBL1710253 0.81 MEN1 (0.35) MEN1KMT2A
SCHEMBL3233538 0.81 MEN1 (0.35) MEN1KMT2A
SCHEMBL3412017 0.81 RPLP1 (0.41) MEN1KMT2ARPLP1RPLP0RPS17
SCHEMBL3412423 0.81 MEN1 (0.34) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262802-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis AG (CH) 2010-12-22 EP disclosed
WO-2009109576-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS AG (CH) 2009-09-11 WO disclosed